| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 4.94 | 0.07 (+1.44%) | 4.13 - 7.01 | 12.5 thousand |
Market data as of 4:00PM 05/23/13. Quotes are delayed by at least 15 min.
| Open | 4.93 |
|---|---|
| Previous Close | 4.87 |
| Day's Range | 4.91 - 4.99 |
| Market Cap | 64.9M |
| Avg Volume (10 Day) | 11.9K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.52 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for LPTN
| LPTN | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -46.17% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 12.68 |
| Company | Last | Change |
|---|---|---|
| Alcobra Ltd | 7.21 | -4.50% |
| Synthetic Biologics Inc | 1.38 | -2.13% |
| MediciNova Inc | 3.17 | -0.31% |
| Arrowhead Research Corp | 2.15 | -1.38% |
| Oramed Pharmaceuticals Inc | 9.20 | -3.26% |
Data is delayed by at least 15 min.